9 May 2017 16:39
NMC Health plc
Grant of options
London, 9 May 2017: NMC Health plc (LSE:NMC) ('the Company'), the leading integrated healthcare provider operating across the United Arab Emirates (UAE), announces that on 9 May 2017 it granted awards over a total of 150,435 Ordinary shares under its Deferred Share Bonus Plan.
These awards, by way of nil-cost options, were made to Directors and PDMRs of the Company as follows:
Name of individual | Director/PDMR | Number of shares subject to award |
Dr B R Shetty | Director | 39,583 |
Mr P. Manghat | Director | 33,493 |
Mr S. Krishnamoorthy | PDMR | 21,923 |
Dr C R Shetty | PDMR | 21,923 |
Mr R Cherry | PDMR | 21,212 |
Mr S. Watkins | PDMR | 12,301 |
Under the terms of the Company's Short Term Incentive Plan, two-thirds of any earned bonus is to be provided in the form of a share award which provides that such shares are only released to participants after a deferral period of one-year in relation to 50% of the share award and two-years in relation to the remaining 50% of the award.
The DSBP is the plan which the Company is operating to deliver such deferred shares to scheme participants. The above award is in relation to the bonus earned pursuant to the 2016 Short Term Incentive Plan.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||||
a) | Name | Dr B R Shetty Mr Prasanth Manghat Mr Suresh Krishnamoorthy Dr C R Shetty Mr Roy Cherry Mr Simon Watkins
| ||||||||||||||
2 | Reason for the notification | |||||||||||||||
a) | Position/status | Directors and PDMRs of the Company | ||||||||||||||
b)
| Initial notification /Amendment | Initial notification | ||||||||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||
a) | Name | NMC Health plc | ||||||||||||||
b) | LEI | 2138008YQEVWBE1V2M52 | ||||||||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||
a)
| Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares
ISIN: GB00B7FC0762 | ||||||||||||||
b) | Nature of the transaction | Grant of nil-cost options
| ||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||
d) | Aggregated information - volume - Price - Total | N/A
| ||||||||||||||
e) | Date of the transaction | 9 May 2017 | ||||||||||||||
f) | Place of the transaction | Not on a trading venue | ||||||||||||||
Contacts
NMC |
|
Simon Watkins, Group Company Secretary | +44 (0)20 3205 7313 |
|
|
Media |
|
FTI Consulting, London |
|
Matthew Cole | +44 (0)20 3727 1101 |
|
|
FTI Consulting, Gulf |
|
Shane Dolan | +971 (0)4 437 2100 |